OPA1 Dominant Optic Atrophy: Diagnostic Approach in the Pediatric Population

• Published in: Current issues in molecular biology Vol. 45; no. 1; pp. 465 - 478
• Main Authors: Arruti, Natalia, Rodríguez-Solana, Patricia, Nieves-Moreno, María, Guerrero-Carretero, Marta, Del Pozo, Ángela, Montaño, Victoria E F, Santos-Simarro, Fernando, Rikeros-Orozco, Emi, Delgado-Mora, Luna, Vallespín, Elena, Noval, Susana
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 05.01.2023; MDPI AG
• Subjects: dominant optic atrophy; Kjer type; mitochondrial neuropathies; OPA1; dominant optic atrophy; mitochondrial neuropathies; OPA1; Kjer type
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb45010030

A clinical and genetic study was conducted with pediatric patients and their relatives with optic atrophy 1 ( mutations to establish whether there is a genotype-phenotype correlation among the variants detected within and between families. Eleven children with a confirmed mutation were identified during the study period. The main initial complaint was reduced visual acuity (VA), present in eight patients of the cohort. Eight of eleven patients had a positive family history of optic atrophy. The mean visual acuity at the start of the study was 0.40 and 0.44 LogMAR in the right and left eye, respectively. At the end of the study, the mean visual acuity was unchanged. Optical coherence tomography during the first visit showed a mean retinal nerve fiber layer thickness of 81.6 microns and 80.5 microns in the right and left eye, respectively; a mean ganglion cell layer of 52.5 and 52.4 microns, respectively, and a mean central macular thickness of 229.5 and 233.5 microns, respectively. The most common visual field defect was a centrocecal scotoma, and nine out of eleven patients showed bilateral temporal disc pallor at baseline. Sequencing of showed seven different mutations in the eleven patients, one of which, NM_130837.3: c.1406_1407del (p.Thr469LysfsTer16), has not been previously reported. Early diagnosis of dominant optic atrophy is crucial, both for avoiding unnecessary consultations and/or treatments and for appropriate genetic counseling.